Third Pole Therapeutics

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Third Pole Therapeutics Announces First Patient Dosed in Feasibility Study with eNOfit™ Portable Inhaled Nitric Oxide Delivery System

Details:

eNOfit is a miniaturized, portable inhaled nitric oxide (iNO) generator and delivery system for the ambulatory treatment of patients suffering from pulmonary hypertension (PH) associated with Interstitial Lung Disease (ILD).

Lead Product(s): Nitric Oxide

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: eNOfit

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 11, 2023

ASK
US

Upload
your Marketing & Sales content

Third Pole Therapeutics

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) Platform

Details:

Third Pole's technology generates pure inhaled nitric oxide (iNO) for therapeutic use and delivers it to the patient on demand, providing clinicians with greater flexibility than with iNO therapeutics stored in compressed gas cylinders.

Lead Product(s): Nitric Oxide

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Undisclosed

Deal Size: $32.0 million Upfront Cash: Undisclosed

Deal Type: Financing December 14, 2022

ASK
US

Upload
your Marketing & Sales content